Topical 5-Aminolevulinic Acid Photodynamic Therapy for the Treatment of Condyloma Acuminatum: a Multicenter, Randomized, CO2 Laser-Controlled Trial
TU Ping,ZHENG He-yi,GU Heng,XU Jin-hua,WANG Xiu-li,CHEN Wei,LI Jun,CHEN Kun,LU Xiao-nian,WANG Hong-wei,ZHU Xue-jun
DOI: https://doi.org/10.3760/j.issn:0412-4030.2007.02.001
2007-01-01
Chinese Journal of Dermatology
Abstract:Objective To evaluate the safety and efficacy of topical 5-aminolevulinic acid photody- namic therapy (ALA-PDT) in the treatment of condyloma acuminatum.Methods This multicenter,ran- domized,open,parallel,CO_2 laser-controlled clinical trial was conducted at 5 research sites in China. Patients with condyloma acuminatum were randomly assigned to the ALA-PDT group or the CO_2 laser (control) group in an allocation ratio of 3:1.The treatment was repeated weekly if necessary,but no more than 3 times.The primary efficacy endpoint was the wart clearance rate 1 week after the last treatment.The recurrence rate was evaluated at weeks 4,8,and 12 after the treatment ended.The laboratory examinations were performed before and at the end of the treatment.Results A total of 453 patients with condyloma acuminatum were enrolled in the clinical trial.Of these,442 (97.57%) patients completed the trial (331 in the ALA-PDT group,and 111 in the control group).At 1 week after the last treatment,98.42% and 100% of the base line warts were eliminated in the ALA-PDT group and the control group,respectively (P0.05).The clearance rate of condylomata acuminata at male urethral orifice was 99.43% in the ALA-PDT group and 100% in the control group (P0.05).The overall recurrence rate calculated for the whole fol- low-up period was significantly lower in the ALA-PDT group than in the control group (10.77% vs 33.33%, P0.0001),and the recurrence of condyloma acuminatum at male urethra orifice was also significantly decreased in the ALA-PDT group than in the control group (10.53% vs 36.36%,P0.0001).There was no systemic adverse event in either group.The incidence of local adverse events was significantly lower in the ALA-PDT group than in the control group (7.67% vs.53.57%,P0.0001).The main adverse event in the ALA-PDT group was mild erosion,whereas the adverse events in the control group were more com- mon and severe,including pain,ulcer,and even scarring (n=14).Conclusions The results confirm that topical ALA-PDT is a safe and effective treatment with low recurrence rate for condyloma acuminatum, especially for this condition at urethral orifice.